NIPRO

Investor Relations

IR News

February 9, 2026
Consolidated Financial Results for the Nine Months Ended December 31, 2025 [Japanese GAAP] / Notice Regarding Recording of Extraordinary Income (Gain on Step Acquisition) / IR Materials
December 9, 2025
The 73rd Interim Shareholders’ Newsletter
November 21, 2025
Toward NIPRO's Sustainable Growth

Index

News Release

March 18, 2026
Announcement of Spryte Medical, a US Affiliate of NIPRO, First Participants Enrolled in the “INSYTE” US Pivotal Trial evaluating the nOCT Imaging System during Brain Aneurysm Treatment(272KB)
March 11, 2026
Notice Concerning the Establishment of the Record Date for the Year-End Dividend(105KB)
March 10, 2026
Notice of Organizational Changes and Consolidation of U.S. Subsidiaries in Vascular Division(224KB)

Index